The Plain Record

Neutral daily news — clear headlines, complete facts.

National

HHS Increases Recommended Limits for Kratom Component Amid Safety Debate

Federal health officials have increased the recommended limits for a kratom-related substance despite warnings from the FDA and reports of 5,000 overdose deaths.

Background: The Electoral College, explained: how the United States actually elects a president

Published November 15, 2026 at 7:06 PM EST

The short answer

Federal health officials have increased the recommended limits for a kratom-related substance despite warnings from the FDA and reports of 5,000 overdose deaths. Kratom, a Southeast Asian plant that acts on opioid receptors, has become a billion-dollar industry in the United States while drawing conflicting responses from health officials and regulators.

HHS Increases Recommended Limits for Kratom Component Amid Safety Debate

The Facts

Who
Department of Health and Human Services (HHS), American Kratom Association, and the Food and Drug Administration (FDA).
What
A shift in federal recommendations regarding 7-OH, a substance found in or related to kratom products.
When
July and 'last month' (relative to the source's unreported publication date)
Where
United States
Why
HHS increased the recommended levels of a kratom-related synthetic substance by 20-fold, despite FDA warnings and reports of thousands of overdose deaths linked to the plant.

Kratom, a Southeast Asian plant that acts on opioid receptors, has become a billion-dollar industry in the United States while drawing conflicting responses from health officials and regulators. Families of four deceased men told "60 Minutes" their sons used the substance for energy or to manage other addictions before their deaths. While the American Kratom Association (AKA) describes the plant as a safe herbal supplement, the Food and Drug Administration (FDA) warns against its use due to risks of liver toxicity, seizures, and addiction.

The plant's leaves have been used for generations in Southeast Asia as a stimulant or tea. In the U.S., it is sold in tens of thousands of locations, including gas stations and online retailers. According to the Centers for Disease Control and Prevention (CDC), kratom was detected in more than 5,000 overdose deaths between 2020 and 2024. Justin Brower, a toxicologist at NMS Labs, stated that fatalities linked to the substance have increased approximately tenfold since 2014, with dozens of cases attributed solely to kratom.

Federal regulatory policy has recently shifted regarding 7-OH, a concentrated synthetic substance related to kratom. In July, the federal government announced it would restrict 7-OH and three related substances. However, the Department of Health and Human Services (HHS) changed its recommendation the following month, proposing a 20-fold increase in the allowable amount of 7-OH in products. HHS stated that neither political pressure nor contributions influenced this change, while Dr. Andrew Kolodny of Brandeis University compared the industry's lobbying tactics to those previously used by the manufacturer of OxyContin.

The American Kratom Association, which lobbies the White House and Congress, maintains a distinction between natural kratom and "chemically manipulated products." Public filings indicate millions of dollars have been spent on lobbying and political contributions. Supporters in the government have helped ensure it remains legally available in most states, even as health experts like Kolodny argue its effects are similar to oxycodone and heroin.

This regulatory shift affects consumers who purchase kratom products in retail stores and gas stations across the United States. While the exact number of active users was not reported, the industry has grown into a billion-dollar market. For individuals using kratom to manage opioid addiction or for energy, the increased allowance of 7-OH—a 20-fold rise from previous federal recommendations—changes the potency of products available. The FDA continues to advise against all kratom use, citing risks of substance use disorder and organ damage.

The policy change has implications for federal oversight and state-level legality. Currently, kratom remains legal in most states, but the conflicting messages between the FDA’s warnings and the HHS’s new, higher limits for synthetic components create a complex environment for small-business owners and distributors. For families and health advocates, the concern centers on the potential for increased addiction and fatalities, given that the CDC already linked the substance to 5,000 deaths over a four-year period.

What happens next involves the implementation of these new HHS recommendations and continued monitoring by forensic labs. Toxicologists like Justin Brower continue to track the rising death toll, which he reported has increased tenfold over the last decade. While HHS has declined interviews, their revised stance on 7-OH levels is the current recommendation for federal policy. Future legislative actions or potential FDA interventions will depend on further studies of kratom's health impacts and the ongoing lobbying efforts.

Timeline of what happened

Key dates and decisions, in the order they occurred.

  1. 2014

    Fatalities linked to kratom begin a tenfold increase over next decade

  2. 2020

    CDC begins tracking kratom in 5,000 overdose deaths through 2024

  3. July 2024

    Federal government announces restrictions on 7-OH and related substances

  4. October 2024

    HHS recommends 20-fold increase in allowed 7-OH levels

Summaries are written by The Plain Record to state the facts of a story plainly and without political slant. Drafted with AI assistance and checked against the source record before publication. See how we report, or report a correction.

← Back to the front page

Questions readers ask

What happened: HHS Increases Recommended Limits for Kratom Component Amid Safety Debate?

A shift in federal recommendations regarding 7-OH, a substance found in or related to kratom products.

Who is involved?

Department of Health and Human Services (HHS), American Kratom Association, and the Food and Drug Administration (FDA).

When did this happen?

July and 'last month' (relative to the source's unreported publication date)

Where did this happen?

United States

Why does this matter?

HHS increased the recommended levels of a kratom-related synthetic substance by 20-fold, despite FDA warnings and reports of thousands of overdose deaths linked to the plant.